Impact on Dyskinesia in Advanced Parkinson’s Disease Patients Treated with LCIG: Analysis from the COSMOS Study
Objective: Analyze the impact of levodopa-carbidopa intestinal gel (LCIG) treatment on dyskinesia duration and severity in advanced Parkinson’s disease (APD) patients participating in the COSMOS…Effect of the mGlu2/3 orthosteric agonist LY-404,039 on abnormal involuntary movements and parkinsonism in the 6-OHDA-lesioned rat
Objective: To assess the effect of LY-404,039 on dyskinesia and parkinsonism in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson’s disease (PD). Background: LY-404,039 is an…Adherence to medication among Serbian Parkinson’s disease patients: a cross-sectional study
Objective: This study aimed to explore patients’ adherence to antiparkinsonian medication, and to determine factors associated with low adherence among Serbian PD patients. Background: Adherence…Opicapone in clinical practice in Parkinson’s disease patients with motor fluctuations and complications of therapy at baseline: findings from the OPTIPARK study
Objective: This post-hoc analysis evaluated the effects of opicapone (OPC) treatment in patients with Parkinson’s disease (PD) who experience motor fluctuations and complications of therapy…Wearable sensor motor outcomes across patients with Parkinson’s disease from Asian, Black, and Caucasian ethnicity in the United Kingdom
Objective: To determine the effect of ethnic background on motor scores in people with Parkinson’s disease (PwP) using objective measurement. Background: Limited evidence has suggested…An Unusual Case of Multiple Systems Atrophy with Long Disease Duration, Severe Gliosis, and Scant Synuclein Pathology
Objective: To describe a pathologically unusual case of Multiple systems atrophy (MSA) with severe widespread gliosis and neuronal loss with scant alpha-synuclein (aSyn) pathology. Background:…An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series
Objective: To evaluate diagnostic criteria for corticobasal degeneration (CBD) in relation to pathology and disease course. Background: The overlapping features of CBD and related conditions…A Rare Case of Reversible Acute Parkinsonism in Fulminant HIV Encephalopathy
Objective: - Background: HIV infection of the central nervous system can be a result of direct neuroinflammatory processes or by opportunistic infections. Movement disorders in…ELECTRICAL ACTIVITY OF THE MASTICATORY MUSCLES OF PARKINSONIANS INFLUENCED BY THE USE OF REMOVABLE DENTAL PROSTHESIS
Objective: Analyze the influence of the types of dental prosthesis on the electromyographic activity of the masticatory muscles; masseter and temporal anterior in parkinsonians. Background:…Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database
Objective: To describe the development and organization of the Consortium for Global Diversity in Parkinson’s Disease (CDG-PD), created in 2020 with a broad aim to…
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 132
- Next Page »